Fengying Gao Selected Research

Pneumonia (Pneumonitis)

1/2017

microRNA-1246 mediates lipopolysaccharide-induced pulmonary endothelial cell apoptosis and acute lung injury by targeting angiotensin-converting enzyme 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fengying Gao Research Topics

Disease

9	Acute Lung Injury 01/2022 - 10/2013
6	Lung Injury 01/2022 - 10/2013
5	Infections 10/2022 - 02/2019
2	Inflammation (Inflammations) 01/2024 - 04/2015
2	Fibrosis (Cirrhosis) 01/2022 - 04/2015
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2015
2	Necrosis 01/2020 - 04/2015
2	Reperfusion Injury 04/2015 - 10/2014
1	Bites and Stings (Sting) 11/2023
1	Virus Diseases (Viral Diseases) 02/2023
1	Hemolysis 02/2023
1	Cytomegalovirus Infections (Inclusion Disease) 01/2022
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Neoplasms (Cancer) 10/2020
1	Hypertriglyceridemia 09/2020
1	Perinatal Death 09/2020
1	Pancreatitis 09/2020
1	Sepsis (Septicemia) 05/2019
1	Burns 05/2019
1	Adenocarcinoma of Lung 05/2019
1	Pneumonia (Pneumonitis) 01/2017
1	Obesity 01/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013

Drug/Important Bio-Agent (IBA)

9	Angiotensin-Converting Enzyme 2IBA 01/2022 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2015
4	CytokinesIBA 01/2022 - 01/2015
3	Messenger RNA (mRNA)IBA 10/2020 - 04/2015
3	Bleomycin (Blenoxane)FDA LinkGeneric 04/2015 - 10/2014
2	TNF Receptor-Associated Factor 3IBA 11/2023 - 01/2020
2	Poly I-CIBA 10/2022 - 02/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 04/2015
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2022 - 04/2015
2	LipopolysaccharidesIBA 01/2022 - 01/2017
2	MicroRNAs (MicroRNA)IBA 05/2019 - 01/2017
2	AntioxidantsIBA 04/2015 - 10/2014
2	Therapeutic UsesIBA 04/2015 - 04/2015
1	Antiviral Agents (Antivirals)IBA 01/2024
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 02/2023
1	Heme (Haem)IBA 02/2023
1	Complement C3 (C3 Complement)IBA 02/2023
1	diminazene aceturateIBA 01/2022
1	CollagenIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	angiotensin I (1-7)IBA 10/2020
1	Apolipoprotein C-II (ApoC2)IBA 09/2020
1	Long Noncoding RNAIBA 05/2019
1	Virulence Factors (Pathogenicity Factors)IBA 02/2019
1	Polysaccharides (Glycans)IBA 02/2019
1	Matrix Metalloproteinases (MMPs)IBA 04/2015
1	NAD (NADH)IBA 04/2015
1	InterleukinsIBA 04/2015
1	Oxidoreductases (Dehydrogenase)IBA 04/2015
1	Platelet-Derived Growth FactorIBA 04/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2015
1	InterferonsIBA 04/2015
1	Indicators and Reagents (Reagents)IBA 04/2015
1	Superoxide DismutaseIBA 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015
1	Glutathione (Reduced Glutathione)IBA 04/2015
1	EnzymesIBA 04/2015
1	Connexin 43 (Connexin43)IBA 04/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 04/2015
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2015
1	Collagen Type I (Type I Collagen)IBA 04/2015
1	Angiotensin IIIBA 04/2015
1	Heme Oxygenase-1IBA 04/2015
1	Caspase 3 (Caspase-3)IBA 04/2015
1	quinone (benzoquinone)IBA 04/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2015
1	keishibukuryoganIBA 01/2015
1	PhosgeneIBA 10/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Immunoglobulin M (IgM)IBA 01/2013
1	Lysine (L-Lysine)FDA Link 01/2013
1	Histones (Histone)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2015
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Transplantation 01/2015